Patent · US Active

Organic compounds

US7888351B2 · kind B2 · utility

0Cited by

4References

14Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Daniel Baeschlin · Arlesheim, CH
Garry Fenton · Harlow, GB
Kenji Namoto · Basel, CH
Nils Ostermann · Binzen, DE
Richard Sedrani · Basel, CH
Finton Sirockin · Blotzheim, FR

Key dates

Filing date	Apr 10, 2007
Grant date	Feb 15, 2011
Priority date	—
Expiry date	Jun 22, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the formula;and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.